Johns Hopkins Professor Matthew Johnson Joins Sheppard Pratt’s Psilocybin Research Center

January 19, 2024

What Is Ibogaine?

January 16, 2024

Usona Researchers Discover New Compounds With Psychedelic Properties

January 14, 2024

Cybin: Psilocybin Trial Participants Experience Nearly 80% Reduction in Depression Symptoms

January 4, 2024

Beckley Psytech Secures $50 Million Investment from atai to Advance Short-Duration Psychedelic Therapies

January 4, 2024

Navigating the Psychedelic Renaissance: The Intersection of Medicine, Spirituality and Big Business

January 3, 2024